DK1280535T3 - Processer til fremstilling af clarithromycin polymorfer - Google Patents

Processer til fremstilling af clarithromycin polymorfer

Info

Publication number
DK1280535T3
DK1280535T3 DK00986367T DK00986367T DK1280535T3 DK 1280535 T3 DK1280535 T3 DK 1280535T3 DK 00986367 T DK00986367 T DK 00986367T DK 00986367 T DK00986367 T DK 00986367T DK 1280535 T3 DK1280535 T3 DK 1280535T3
Authority
DK
Denmark
Prior art keywords
clarithromycin
processes
preparation
polymorphs
converting
Prior art date
Application number
DK00986367T
Other languages
Danish (da)
English (en)
Inventor
Igor Lifshitz
Ilya Avrutov
Edi Schwartz
Basem Masarwa
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22640371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1280535(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of DK1280535T3 publication Critical patent/DK1280535T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00986367T 2000-01-11 2000-12-15 Processer til fremstilling af clarithromycin polymorfer DK1280535T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17547700P 2000-01-11 2000-01-11
PCT/US2000/033844 WO2001051059A1 (en) 2000-01-11 2000-12-15 Processes for preparing clarithromycin polymorphs

Publications (1)

Publication Number Publication Date
DK1280535T3 true DK1280535T3 (da) 2005-04-04

Family

ID=22640371

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00986367T DK1280535T3 (da) 2000-01-11 2000-12-15 Processer til fremstilling af clarithromycin polymorfer

Country Status (22)

Country Link
US (2) US6624292B2 (show.php)
EP (1) EP1280535B1 (show.php)
JP (1) JP2003519661A (show.php)
KR (1) KR20020071012A (show.php)
CN (1) CN1450903A (show.php)
AT (1) ATE288758T1 (show.php)
AU (2) AU2261901A (show.php)
BR (1) BR0016992A (show.php)
CA (1) CA2397092A1 (show.php)
DE (1) DE60018119T2 (show.php)
DK (1) DK1280535T3 (show.php)
ES (1) ES2236023T3 (show.php)
HR (1) HRP20020572A2 (show.php)
HU (1) HUP0204252A3 (show.php)
IL (1) IL150698A0 (show.php)
IS (1) IS6463A (show.php)
PL (1) PL356645A1 (show.php)
PT (1) PT1280535E (show.php)
RU (1) RU2002118308A (show.php)
SI (1) SI1280535T1 (show.php)
WO (1) WO2001051059A1 (show.php)
ZA (1) ZA200205229B (show.php)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020070991A (ko) * 1999-12-16 2002-09-11 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 다형체 및 신규의 다형체 ⅳ의 제조 방법
SI1280535T1 (show.php) * 2000-01-11 2005-08-31 Teva Pharma
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
SK13722002A3 (sk) * 2000-02-29 2003-08-05 Teva Pharmaceutical Industries Ltd. Spôsob prípravy klaritromycínu a klaritromycínového medziproduktu, v podstate prostého oxímu a farmaceutický prostriedok, ktorý ho obsahuje
BR0109544A (pt) * 2000-03-28 2003-06-10 Biochemie Gmbh Partìculas granuladas com sabor ocultado
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
ES2288898T3 (es) * 2001-08-13 2008-02-01 Fondazione Salvatore Maugeri - Clinica del Lavoro e della Riabilitazione Uso de composiciones de claritromicina en la fabricacion de un medicamento para el tratamiento de la artritis deformante.
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005061524A2 (en) * 2003-12-22 2005-07-07 Ranbaxy Laboratories Limited Process for the preparation of form ii clarithromycin
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
US20050175584A1 (en) * 2004-01-28 2005-08-11 Paciotti Giulio F. Functionalized colloidal metal compositions and methods
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US20070015719A1 (en) * 2005-07-07 2007-01-18 Elan Pharma International Limited Nanoparticulate clarithromycin formulations
WO2007064595A2 (en) * 2005-11-29 2007-06-07 Bausch & Lomb Incorporated Fluocinolone acetonide drug substance polymorphic interconversion
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CA2773037A1 (en) * 2009-09-02 2011-03-10 Bernard Charles Sherman Clarithromycin extended-release tablet
EP3068394A4 (en) 2013-11-15 2017-04-26 Akebia Therapeutics Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4672056A (en) 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use
KR960000434B1 (ko) 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
GB8721165D0 (en) 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
JP2751385B2 (ja) 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5440505A (en) * 1994-01-21 1995-08-08 Intel Corporation Method and circuitry for storing discrete amounts of charge in a single memory element
US5756473A (en) 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5719272A (en) 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5837829A (en) 1996-04-02 1998-11-17 Abbott Laboratories 9-oximesilyl erythromycin a derivatives
US5808017A (en) 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
DE69730138T2 (de) 1996-07-29 2005-03-03 Abbott Laboratories, Abbott Park Herstellung von kristallinen form ii von clarithromycin
US5858986A (en) * 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US5864023A (en) 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US5852180A (en) 1997-11-17 1998-12-22 Abbott Laboratories Chemical synthesis of 6-O-alkyl erythromycin A
US5932710A (en) 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
US5892008A (en) 1997-12-16 1999-04-06 Abbott Laboratories Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
KR100377159B1 (ko) 1998-09-09 2003-08-19 한미약품공업 주식회사 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
KR20020070991A (ko) * 1999-12-16 2002-09-11 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 다형체 및 신규의 다형체 ⅳ의 제조 방법
SI1280535T1 (show.php) * 2000-01-11 2005-08-31 Teva Pharma
SK13722002A3 (sk) * 2000-02-29 2003-08-05 Teva Pharmaceutical Industries Ltd. Spôsob prípravy klaritromycínu a klaritromycínového medziproduktu, v podstate prostého oxímu a farmaceutický prostriedok, ktorý ho obsahuje

Also Published As

Publication number Publication date
AU2261901A (en) 2001-07-24
HUP0204252A3 (en) 2003-04-28
AU2001222619C1 (en) 2006-01-12
PT1280535E (pt) 2005-04-29
US6987175B2 (en) 2006-01-17
RU2002118308A (ru) 2004-02-20
JP2003519661A (ja) 2003-06-24
ZA200205229B (en) 2003-06-30
AU2001222619B2 (en) 2005-04-28
HUP0204252A2 (hu) 2003-03-28
ATE288758T1 (de) 2005-02-15
AU2001222619B8 (en) 2005-07-14
WO2001051059A1 (en) 2001-07-19
DE60018119T2 (de) 2006-05-04
HRP20020572A2 (en) 2005-04-30
DE60018119D1 (de) 2005-03-17
EP1280535A1 (en) 2003-02-05
US20030216555A1 (en) 2003-11-20
US6624292B2 (en) 2003-09-23
EP1280535B1 (en) 2005-02-09
CA2397092A1 (en) 2001-07-19
BR0016992A (pt) 2002-12-31
EP1280535A4 (en) 2003-02-05
KR20020071012A (ko) 2002-09-11
IL150698A0 (en) 2003-02-12
ES2236023T3 (es) 2005-07-16
SI1280535T1 (show.php) 2005-08-31
IS6463A (is) 2002-07-09
US20020028920A1 (en) 2002-03-07
PL356645A1 (en) 2004-06-28
CN1450903A (zh) 2003-10-22

Similar Documents

Publication Publication Date Title
DK1280535T3 (da) Processer til fremstilling af clarithromycin polymorfer
DE60115785D1 (de) Mit Wasserstoffverbrennung betriebene Heizungsanlage
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
NL1019181A1 (nl) Gestabiliseerd metalloceen-polypropeen.
EP1325123A4 (en) INHIBITION OF STENOSIS OR RESTENOSIS USING P-SELECTINE ANTAGONISTS
BR0006509B1 (pt) construção em barra de reação.
BR0101271B1 (pt) folha composta.
BR0110478B1 (pt) composiÇço aquosa de xampu.
DK1259474T3 (da) Calcium-dicarboxylatethere, fremgangsmåder til fremstilling deraf
IT1319686B1 (it) Procedimento di preparazione di citalopram.
MXPA02002631A (es) Cemento portland rico en yeso..
YU53302A (sh) Postupci za pripremanje polimorfa klaritromicina
ES1052327Y (es) Gasometro de membrana mejorado.
ITTO20010403A0 (it) Boccola lineare, in particolare per consentire la traslazione di due elementi strutturali.
ES1045714Y (es) Pieza para encofrar suelos de edificios.
ES2183543T3 (es) Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica.
ES1048627Y (es) Gasometro de membrana mejorado.
DK1315702T3 (da) Fremgangsmåde til fremstilling af halogen-4-phenoxyquinoliner
ES1047824Y (es) Membrana anticierre aplicada a conectores.
TR200102093T2 (tr) Organ koruyucu çözeltiler
ES1050479Y (es) Membrana de vacio.
BR8103532Y1 (pt) aperfeiçoamentos introduzidos em caixa porta-documentos.
ECSP993252A (es) Macrolidos
NO20001218D0 (no) Det kinetisk kvantiserte system, det lineært akselererte system
ITRM20000040V0 (it) Easy playnet.